Multiple overlapping mechanisms drive myelin destruction, and different peptides target different parts of this cascade
The benefits team called Vida "a cardiometabolic weight loss solution" and framed it as a perk
Unresolved questions and future directions Currently, despite promising prospects in preclinical models, targeting glutamine metabolism faces challenges in clinical trials due to inherent heterogeneity in glutamine metabolism within tumor cells and immune cells, as well as its complex impact on immune responses
Other patients have a harder battle ahead of them
Alexis Cutchins: Yeah, so if a patient has left flank pain, that's useful that's one of the symptoms of renal vein compression or nutcracker
A total of 10,000 gated events were collected per sample